Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out

Anticancer treatments have shown a variable therapeutic outcome that may be partly attributable to the activity of the gut microbiota on the pathology and/or therapies. In recent years, microbiota–drug interactions have been extensively investigated, but most of the underlying molecular mechanisms s...

Descripción completa

Detalles Bibliográficos
Autores principales: Conti, Gabriele, D’Amico, Federica, Fabbrini, Marco, Brigidi, Patrizia, Barone, Monica, Turroni, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859289/
https://www.ncbi.nlm.nih.gov/pubmed/36672796
http://dx.doi.org/10.3390/genes14010055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859289/
https://www.ncbi.nlm.nih.gov/pubmed/36672796
http://dx.doi.org/10.3390/genes14010055

Ejemplares similares